Cencora, Inc.’s $5.5 Billion of Credit Facilities in Connection with its Acquisition of OneOncology
February 03, 2026
Cravath represented the administrative agent, joint lead arrangers and joint bookrunners in connection with $5.5 billion of credit facilities made available to Cencora, Inc., as part of the financing transactions undertaken in connection with its acquisition of OneOncology, a physician‑led national platform empowering independent medical specialty practices rooted in oncology. Cencora, Inc. is a leading global pharmaceutical sourcing and distribution services company. The credit facilities consisted of a $1.5 billion term loan facility, a $3.0 billion term loan facility and a $1.0 billion commitment increase under an existing revolving credit facility. The transaction closed on January 12, 2026.
The Cravath team included partner Tatiana Lapushchik and associates Nastassia Shcherbatsevich Li and Lindsey Corbett on banking matters; partner Ryan J. Patrone and associates Courtney T. Seager and R. Christian Dunn on capital markets matters; partner Arvind Ravichandran and associate Ruth Goldstein Schapiro on tax matters; and associates Anna Mikaelyan and Keanna N. Joseph on executive compensation and benefits matters. Elizabeth Jin also worked on banking matters, Han Wen Zhang worked on capital markets matters and Jonathan Jiang worked on tax matters.
Related Practices & Industries
People
- Photo
-
-
J.D., 2000, Harvard Law Schoolcum laude
-
B.A., 1997, Barnard Collegesumma cum laude
- New York
Education
Admitted In
- Photo
-
-
J.D., 2015, New York University School of LawOrder of the Coif; Florence Allen Scholar, magna cum laude
-
B.S., 2012, University of Floridasumma cum laude
- New York
Education
Admitted In
- Photo
-
-
J.D., 2012, Columbia Law School
-
B.A., 2009, Columbia College
- New York
Education
Admitted In
Related News & Insights
Deals & Cases
June 18, 2025
Cencora, Inc.’s $4.5 Billion Revolving Credit Facility
Cravath represented the administrative agent, joint lead arranger and joint bookrunner in connection with a $4.5 billion revolving credit facility made available to Cencora, Inc., a leading global pharmaceutical sourcing and distribution services company, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The transaction closed on June 4, 2025.
Deals & Cases
June 05, 2025
Cencora, Inc.’s €1 Billion Registered Senior Notes Offering
Cravath represented the underwriters in connection with the €1 billion registered senior notes offering of Cencora, Inc., a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. The transaction closed on May 22, 2025.
Deals & Cases
December 23, 2024
Cencora, Inc.’s $1.8 Billion Registered Senior Notes Offering
Cravath represented the underwriters in connection with the $1.8 billion registered senior notes offering of Cencora, Inc., a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. The transaction closed on December 9, 2024.
Deals & Cases
February 22, 2024
Cencora, Inc.’s Registered Senior Notes Offering
Cravath represented the underwriters in connection with the $500 million registered senior notes offering of Cencora, Inc., a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. The transaction closed on February 7, 2024.
